Spots Global Cancer Trial Database for sbrt
Every month we try and update this database with for sbrt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck | NCT04435938 | Head and Neck N... Squamous Cell C... Squamous Skin C... | Stereotactic Bo... | 60 Years - | McMaster University | |
| Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed By Surgery | NCT00551369 | Lung Cancer | SBRT | 18 Years - | Radiation Therapy Oncology Group | |
| MFOLFIRINOX And Stereotactic Radiotherapy (SBRT) for Pancreatic Cancer With High Risk and Locally Advanced Disease | NCT04089150 | Pancreatic Canc... | Stereotactic Ra... mFOLFIRINOX Gemcitabine + N... Gemcitabine + C... Pancreatoduoden... | 18 Years - 75 Years | Australasian Gastro-Intestinal Trials Group | |
| A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer | NCT05138900 | Non Small Cell ... | SBRT | 18 Years - | Roswell Park Cancer Institute | |
| Phase II Study of SBRT as Treatment for Oligometastases in Prostate Cancer | NCT02192788 | Oligometastatic... | Stereotactic Bo... | 18 Years - | Grupo de Investigación Clínica en Oncología Radioterapia | |
| Proton-Based Stereotactic Ablative Body Radiotherapy for Prostate Cancer | NCT03159676 | Prostate Cancer | Proton beam | 18 Years - | Mayo Clinic | |
| Stereotactic Volumetric Radiotherapy in Prostate Cancer | NCT02423889 | Prostate Cancer | Radiotherapy | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Gut Microbiota And Radiotherapy | NCT02559349 | Lung Tumor | Stool Collectio... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| LIVELUNG - Impact of CGA in Patients Diagnosed With Localized NSCLC Treated With SBRT | NCT05919641 | Non-small Cell ... Stereotactic Bo... Comprehensive G... | Comprehensive G... | 70 Years - | Odense University Hospital | |
| Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma | NCT02339948 | Prostate Adenoc... | SBRT | 18 Years - | GenesisCare USA | |
| SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH) | NCT05718232 | Advanced Hepato... | Lenvatinib TACE SBRT | 18 Years - 75 Years | Sun Yat-sen University | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| SIGNAL During a COVID-19 Pandemic | NCT05037019 | Breast Cancer | Radiation thera... | 50 Years - | Lawson Health Research Institute | |
| Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas | NCT03283605 | Head and Neck S... Metastatic Squa... | SBRT Durvalumab Tremelimumab | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Stereotactic Body Radiotherapy (SBRT) Versus Stereotactic Body Proton Therapy (SBPT) | NCT01511081 | Non-small-cell ... | SBRT (stereotac... SBPT (stereotac... | 18 Years - | M.D. Anderson Cancer Center | |
| Durvalumab and Consolidation SBRT Following Chemoradiation for Locally Advanced Stage III Non-Small Cell Lung | NCT03589547 | Stage III Non-s... | Durvalumab SBRT | 18 Years - | Brown University | |
| Stereotactic Body Radiotherapy (SBRT) for Prostate Cancer | NCT00941915 | Prostate Cancer | SBRT Prostate | 40 Years - 82 Years | Duke University | |
| Trimodality Approach of Low Dose iOnizing Radiation With or Without Neoadjuvant Pembrolizumab and Prostatectomy for Men With Intermediate/High Risk Prostate Cancer (TALON) | NCT04569461 | Prostate Cancer | pembrolizumab Stereotactic bo... Short-term andr... Radical Prostat... | 18 Years - | Duke University | |
| Durvalumab and Stereotactic Radiotherapy for Advanced NSCLC | NCT04786093 | Non Small Cell ... | Stereotactic ra... Durvalumab | 18 Years - | University of Texas Southwestern Medical Center | |
| Pre-Operative Immuno-Modulatory SBRT (POIMS Trial): A Pilot Trial in Early Stage NSCLC | NCT05094544 | Non-small Cell ... | Non-ablative SB... | 18 Years - | University of Kansas Medical Center | |
| Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung | NCT00832780 | Lung Cancer Non Small Cell ... Solid Tumors | Stereotactic Bo... | 18 Years - | New Mexico Cancer Care Alliance | |
| Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer | NCT04262154 | Metastatic Pros... | Atezolizumab Abiraterone Prednisone GnRH analog Stereotactic Bo... Enzalutamide Follow up | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Radiation Therapy for Pediatric Sarcomas | NCT01763970 | Sarcoma Metastatic Dise... Bony Sites | SBRT | 4 Years - 40 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Combination Chemoembolization and Stereotactic Body Radiation Therapy in Unresectable Hepatocellular Carcinoma | NCT02513199 | Hepatocellular ... | SBRT TACE | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer | NCT04302025 | Non-small Cell ... | Alectinib Entrectinib Vemurafenib (En... Cobimetinib (En... Pralsetinib (En... Atezolizumab SBRT Resection Chemotherapy Divarasib | 18 Years - | Genentech, Inc. | |
| Efficacy and Safety of SBRT Followed by Tislelizumab Plus Cetuximab and Irinotecan in Patients With Previously Treated RAS Wild-type Advanced Refractory Colorectal Cancer | NCT05799443 | Colorectal Canc... | Tislelizumab Irinotecan Hydr... cetuximab SBRT | 18 Years - 75 Years | Fujian Cancer Hospital | |
| A Trial of Durvalumab and Tremelimumab in Combination With SBRT in Patients With Metastatic Cancer | NCT03212469 | Head and Neck S... Lung Cancer Oesophageal Can... | Durvalumab Tremelimumab SBRT | 18 Years - | Gustave Roussy, Cancer Campus, Grand Paris | |
| FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy | NCT04491084 | Non Small Cell ... Lung Cancer | FLT3 Ligand (CD... anti-CD40 antib... SBRT | 18 Years - | Albert Einstein College of Medicine | |
| Study of Stereotactic Body Radiation Therapy for Patients After Radical Resection of Pancreatic Cancer With Advanced Stages (T3 or N1) | NCT02461836 | Pancreatic Canc... | Gemcitabine SBRT | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| A Proof of Principle Study of Pembrolizumab With SBRT in TKI mRCC Patients | NCT02599779 | Stage IV Renal ... | Pembrolizumab Stereotactic Bo... | 18 Years - | Sunnybrook Health Sciences Centre | |
| SBRT for Oligometastatic Castration-Refractory Prostate Cancer | NCT02816983 | Prostate Cancer | SBRT | 18 Years - | Mayo Clinic | |
| Evaluation of Single Session Stereotactic Body Radiotherapy | NCT00492817 | Spinal Neoplasm... | Stereotactic Bo... | - | M.D. Anderson Cancer Center | |
| Stereotactic MRI-guided On-table Adaptive Radiation Therapy (SMART) for Locally Advanced Pancreatic Cancer | NCT03621644 | Pancreatic Canc... | Stereotactic MR... | 18 Years - | Viewray Inc. | |
| Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics) | NCT02013297 | Brain Metastasi... Spinal Tumors Lung Tumors Ependymoma | SBRT treatment | 18 Months - 20 Years | Centre Leon Berard | |
| Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer | NCT02228356 | Neoplasm Metast... | Stereotactic Bo... | 18 Years - 100 Years | Universitair Ziekenhuis Brussel | |
| Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer | NCT04699539 | Treatment | SBRT Chemotherapy | 18 Years - 75 Years | Changhai Hospital | |
| Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma | NCT04166734 | Advanced Malign... | Pembrolizumab Stereotactic Bo... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously | NCT01543672 | Lung Cancer Metastatic Lung... | Stereotactic Bo... Stereotactic Bo... | 18 Years - | The Netherlands Cancer Institute | |
| A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC | NCT06434740 | Non-Small-Cell ... | Stereotactic Bo... Puterizumab | 18 Years - | Sir Run Run Shaw Hospital | |
| SBRT in Combination With Sintilimab and GM-CSF for the Treatment of Advanced NSCLC | NCT04106180 | NSCLC Stage IV | GM-CSF Sintilimab SBRT | 18 Years - | Fudan University | |
| Phase I/II Study of SBRT and GC4711 for Centrally Located or Large NSCLC | NCT04476797 | SBRT NSCLC Non-metastatic | GC4711 +SBRT Placebo +SBRT | 18 Years - | Galera Therapeutics, Inc. | |
| SBRT as Bridging Therapy for Hepatocellular Carcinoma Patients on Transplant Waitlist | NCT03950102 | Hepatocellular ... | SBRT | 18 Years - | The University of Hong Kong | |
| Phase II Trial of SBRT + or - IMRT in Treatment of Patients With Clinically Confined Prostate Adenocarcinoma | NCT02339948 | Prostate Adenoc... | SBRT | 18 Years - | GenesisCare USA | |
| A Study of MRI-guided High-dose Radiation Therapy in Prostate Cancer | NCT04997018 | Prostate Cancer | Radiation Thera... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy | NCT05585554 | Pancreatic Canc... | MRIdian | 18 Years - | Viewray Inc. | |
| Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy | NCT02864615 | Metastatic Rena... | SBRT | 18 Years - 75 Years | Kidney Cancer Research Bureau | |
| Stereotactic Body Radiation Therapy (SBRT) in Metastatic Non-small Cell Lung Cancer | NCT01185639 | Non-Small-Cell ... Liver Cancer Adrenal Cancer | stereotactic bo... | 18 Years - 90 Years | Wake Forest University Health Sciences | |
| Intermittent Androgen Deprivation Therapy With or Without Stereotactic Body Radiotherapy for Molecularly Identified Hormone Sensitive Oligometastatic Prostate Cancer | NCT04619069 | Prostate Cancer | SBRT Hormone therapy | 18 Years - | Sunnybrook Health Sciences Centre | |
| QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy. | NCT03387085 | Triple Negative... | Aldoxorubicin H... N-803 ETBX-011 ETBX-051 ETBX-061 GI-4000 GI-6207 GI-6301 haNK for Infusi... avelumab bevacizumab Capecitabine Cisplatin Cyclophosphamid... 5-Fluorouracil Leucovorin nab-Paclitaxel SBRT | 18 Years - | ImmunityBio, Inc. | |
| Borderline Resectable Pancreatic Cancer Neoadjuvant Chemoradiotherapy Clinicaltrial-1 | NCT03777462 | Pancreatic Canc... | Neoadjuvant gem... Neoadjuvant gem... Neoadjuvant S-1... | 18 Years - 80 Years | Changhai Hospital | |
| Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer | NCT05721846 | Pancreatic Canc... | Nivolumab Ipilimumab SBRT TGFβ-B-15 pepti... | 18 Years - | Herlev Hospital | |
| SRS Study in Patients With Non-Small Cell Lung Cancer | NCT00489008 | Lung Cancer | Stereotactic Bo... | - | M.D. Anderson Cancer Center | |
| Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | NCT02759783 | Prostate Cancer Breast Cancer Carcinoma, Non-... | SBRT Standard of Car... | 18 Years - | Royal Marsden NHS Foundation Trust | |
| SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors | NCT05387044 | NSCLC Stage IV | SBRT | 18 Years - | Zhejiang Cancer Hospital | |
| Combined Immunotherapies in Metastatic ER+ Breast Cancer | NCT04563507 | Breast Cancer | Stereotactic Bo... Letrozole 2.5Mg... Palbociclib 125... | 18 Years - 90 Years | Weill Medical College of Cornell University | |
| Stereotactic Volumetric Radiotherapy in Prostate Cancer | NCT02423889 | Prostate Cancer | Radiotherapy | 18 Years - | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | |
| Sequential TACE and SBRT Followed by ImmunoTherapy for Downstaging HCC for Hepatectomy | NCT03817736 | HCC | TACE SBRT Immune Checkpoi... | 18 Years - 75 Years | The University of Hong Kong | |
| Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer | NCT05721846 | Pancreatic Canc... | Nivolumab Ipilimumab SBRT TGFβ-B-15 pepti... | 18 Years - | Herlev Hospital | |
| Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC | NCT05021328 | NSCLC | Toripalimab Anlotinib SBRT 7Gy✖️5 QD | 18 Years - | Hubei Cancer Hospital | |
| Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Prostate Cancer | NCT04599686 | Treatment | ADT SBRT | 18 Years - 99 Years | Changhai Hospital | |
| Low-dose Radiotherapy Plus Chemotherapy With Gem-based Doublets and Stereotactic Radiotherapy for Advanced Pancreatic Cancer | NCT02416609 | Pancreatic Canc... | LDR Gem-based doubl... SBRT | 18 Years - | Azienda Ospedaliero-Universitaria di Modena | |
| BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab | NCT04933903 | Non Small Cell ... | Ipilimumab Nivolumab SBRT | 18 Years - | Brown University | |
| SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study) | NCT06009029 | Locally Advance... | Stereotactic bo... Zimberelimab (G... | 18 Years - 75 Years | Peking University Third Hospital | |
| The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy | NCT06342323 | Lung Cancer Liver Cancer Pancreatic Canc... Renal Cell Carc... | SBRT | 18 Years - | Peking University Third Hospital | |
| Stereotactic Ablative Radiation Therapy for Prostate Cancer | NCT05668351 | Prostate Cancer | SUPR-SABR treat... | 18 Years - | Medical University of South Carolina | |
| BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab | NCT04933903 | Non Small Cell ... | Ipilimumab Nivolumab SBRT | 18 Years - | Brown University | |
| MONDRIAN: Multi-omics Integrative Modelling for Stereotactic Body Radiotherapy in Early-stage Non-small Cell Lung Cancer | NCT05974475 | Lung Neoplasm M... | SBRT Surgery | 18 Years - | European Institute of Oncology | |
| CRT Versus Surgery for Retroperitoneal or Paraaortic Lymph Node Recurrence of CRC | NCT03725254 | Colorectal Canc... Retroperitoneal... Para-aortic Lym... | lymphadenectomy chemoradiothera... | 18 Years - 75 Years | Fudan University | |
| Plasma Biomarker in Predicting Response and Toxicity in HCC Patients Treated With Checkpoint Inhibitors With or Without SBRT | NCT06408753 | Hepatocellular ... Stereotactic Bo... | sterotatic body... | 18 Years - | The University of Hong Kong | |
| Stereotactic Body Radiotherapy (SBRT) Followed by Immunotherapy in Liver Cancer | NCT03203304 | Hepatocellular ... | Nivolumab Ipilimumab | 18 Years - | University of Chicago | |
| a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer | NCT06360653 | Endometrial Can... | Stereotactic Po... | 18 Years - 80 Years | ARNAS Civico Di Cristina Benfratelli Hospital | |
| Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy | NCT05585554 | Pancreatic Canc... | MRIdian | 18 Years - | Viewray Inc. | |
| Immunotherapy and SBRT for Metastatic Head and Neck Carcinomas | NCT03283605 | Head and Neck S... Metastatic Squa... | SBRT Durvalumab Tremelimumab | 18 Years - | Centre hospitalier de l'Université de Montréal (CHUM) | |
| Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer | NCT03431415 | Non-small Cell ... Surgery Stereotactic Bo... | Anatomical Segm... Stereotactic Bo... | 18 Years - 75 Years | Institut universitaire de cardiologie et de pneumologie de Québec, University Laval | |
| Prospective Observational Basket Study of Stereotactic Body Radiation Therapy for OligoMetastatic Patients From Rare Tumors | NCT05903261 | Oligometastatic... | SBRT | 18 Years - | Istituto Clinico Humanitas | |
| Stereotactic Body Radiotherapy for Osseous Low Alpha-Beta Resistant Metastases for Pain Relief | NCT04177056 | Bone Metastases Prostate Cancer Breast Cancer Renal Cell Carc... Melanoma | SBRT | 18 Years - | Hamilton Health Sciences Corporation | |
| Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer | NCT02339701 | Prostate Cancer | IMRT SBRT | 18 Years - | Chinese University of Hong Kong | |
| SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy | NCT05990192 | Ovarian Cancer ... | Niraparib oral ... SBRT | 18 Years - | Institute of Cancer Research, United Kingdom | |
| The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy | NCT06342323 | Lung Cancer Liver Cancer Pancreatic Canc... Renal Cell Carc... | SBRT | 18 Years - | Peking University Third Hospital | |
| Stereotactic Body Radiotherapy Dose Escalation in Pancreatic Cancer | NCT02454140 | Pancreatic Canc... | SBRT | 18 Years - | University of California, San Diego |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
